Innscitech

If you are preparing for an audit, these are the "usual suspects" that end up on a 483:

1. Inadequate Investigations: Failure to thoroughly investigate any unexplained discrepancy or batch failure (the #1 most common finding).

2. SOP Non-compliance: Having written procedures but failing to follow them in practice.

3. Laboratory Controls: Lack of scientifically sound test procedures or data integrity issues.

4. Cleaning/Sanitation: Evidence of contamination or poor equipment maintenance.

5. Training: Lack of documented training for personnel performing critical tasks.

#483

Nobel Peace Prize 2025 live: Venezuela’s Maria Corina Machado wins

The prestigious Nobel Peace Prize for 2025 has been awarded at the Norwegian Nobel Institute in Oslo to Venezuelan opposition politician Maria Corina Machado. It is the highlight of the week of announcements from October 6 to 13.
A total of 338 nominations had been submitted for the award, including 244 individuals and 94 organisations

The Nobel Peace Prize has been awarded 105 times to 142 Nobel Prize laureates between 1901 and 2024, 111 individuals and 31 organisations. Since the International Committee of the Red Cross has been awarded the Nobel Peace Prize three times (in 1917, 1944 and 1963), and the Office of the United Nations High Commissioner for Refugees has been awarded the Nobel Peace Prize two times (in 1954 and 1981), there are 28 individual organisations which have been awarded the Nobel Peace Prize. Click on the links to get more information.

https://www.nobelprize.org/prizes/lists/all-nobel-peace-prizes/

Cancer Uses Mitochondria to Reprogram Neighboring Cells

A new discovery reveals how cancer cells can manipulate their surroundings to support tumor growth. Recent research has shown that cancer cells can transfer mitochondria—the cell’s energy-producing organelles—to nearby noncancerous cells, effectively reprogramming them to favor tumor survival and expansion.

Scientists found that this mitochondrial transfer alters the metabolism and behavior of neighboring cells, converting them into “tumor-supportive” partners. These reprogrammed cells begin to produce nutrients, growth factors, and signaling molecules that help cancer cells resist stress, grow faster, and evade the immune system.

This finding changes how researchers view the tumor microenvironment, highlighting that cancer is not just a disease of individual cells but a cooperative ecosystem where energy and information are exchanged.

By blocking mitochondrial transfer or interfering with the metabolic changes it causes, future therapies might disrupt this cellular collaboration—potentially stopping cancer growth or improving the effectiveness of existing treatments.

Baxdrostat: A Promising New Option for Hard-to-Treat Hypertension

A major step forward may be on the horizon for people struggling with high blood pressure that doesn’t respond to standard therapy.

A recent clinical trial published on August 30 in the New England Journal of Medicine revealed encouraging results for baxdrostat, a novel drug from a new class known as aldosterone synthase inhibitors.

Baxdrostat works by blocking the enzyme that drives production of aldosterone, a hormone that can raise blood pressure by increasing sodium and water retention. By targeting this mechanism, the drug helps reduce blood pressure through a more specific and physiologic approach.

In the multicenter trial, patients with resistant hypertension—those whose blood pressure remained high despite taking at least three different antihypertensive drugs—received baxdrostat or a placebo.
• Those treated with baxdrostat experienced significantly greater reductions in systolic blood pressure compared to placebo.
• Importantly, the drug was well tolerated and did not cause major safety concerns, including no excessive drop in cortisol levels or potassium imbalance, which were potential risks with earlier compounds in this drug class.

Experts say the findings could mark a new era in hypertension management, offering hope for millions worldwide whose blood pressure remains uncontrolled despite current medications.

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/person-covey-inc-711191-09232025

Persōn & Covey, Inc. - 711191 - 09/23/2025 CGMP/Finished Pharmaceuticals/Adulterated

Nobel Prize in Chemistry 2025 The Nobel Prize in Chemistry 2025 was awarded jointly to Susumu Kitagawa, Richard Robson and Omar M. Yaghi "for the development of metal–organic frameworks"